anmelden
25 € WM-Startbonus + 5 € Torbonus für jeden deutschen Treffer*
NYSE International 100
10.609,65
PKT
-6,77
PKT
-0,06
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NYSE International 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.02.24 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 01.02.24 | Sanofi Overweight | Barclays Capital | |
| 01.02.24 | Unilever Overweight | Barclays Capital | |
| 01.02.24 | Deutsche Bank Equal Weight | Barclays Capital | |
| 01.02.24 | GSK Halten | DZ BANK | |
| 01.02.24 | Santander Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.02.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 01.02.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 01.02.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 01.02.24 | ING Group Sector Perform | RBC Capital Markets | |
| 01.02.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 01.02.24 | Santander Buy | UBS AG | |
| 01.02.24 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 01.02.24 | Philips Sell | UBS AG | |
| 01.02.24 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 01.02.24 | Sanofi Buy | UBS AG | |
| 01.02.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.02.24 | SAP Add | Baader Bank | |
| 01.02.24 | GSK Buy | Deutsche Bank AG | |
| 01.02.24 | GSK Buy | Deutsche Bank AG | |
| 01.02.24 | Deutsche Bank Buy | UBS AG | |
| 01.02.24 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 01.02.24 | ING Group Buy | UBS AG | |
| 01.02.24 | Deutsche Bank Buy | Warburg Research | |
| 01.02.24 | Deutsche Bank Overweight | JP Morgan Chase & Co. | |
| 01.02.24 | Deutsche Bank Outperform | RBC Capital Markets | |
| 31.01.24 | Novartis Kaufen | DZ BANK | |
| 31.01.24 | Santander Halten | DZ BANK | |
| 31.01.24 | Santander Sector Perform | RBC Capital Markets | |
| 31.01.24 | Allianz Overweight | JP Morgan Chase & Co. | |
| 31.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 31.01.24 | BBVA Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 31.01.24 | GSK Buy | UBS AG | |
| 31.01.24 | BBVA Buy | UBS AG | |
| 31.01.24 | Novartis Buy | UBS AG | |
| 31.01.24 | Santander Buy | UBS AG | |
| 31.01.24 | AstraZeneca Sell | UBS AG | |
| 31.01.24 | Diageo Overweight | Barclays Capital | |
| 31.01.24 | BBVA Overweight | Barclays Capital | |
| 31.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. |